Bayer’s odds of successfully appealing the $25 million Roundup trial verdict is “improved” after the recent selection of a three-judge panel overseeing the case in the 9th Circuit, according to Susquehanna. 1.Legal analyst Tom Claps said the panel “appears to be a ‘good draw’ for Bayer, as it consists of 2 Republicans (and 1 Democrat)” 2.Also said Republicans have experiences and issued rulings in the past that “could be viewed as favorable to Bayer” 3.Expects an appellate decision in 1H of 2021 4.BAYN GR has 17 buys, 12 holds, 1 sell; avg PT 69 euros: Bloomberg data 5.NOTE: Earlier, Bayer Downgraded as Fundamentals Worse than Litigation: Barclays 6.NOTE: Sept. 30, Bayer Slumps as Bleak Crop Outlook Saps Monsanto Rationale (1) 7.NOTE: Sept. 28, Bayer Confronts Judge’s Deadline as Roundup Settlements Lag.
展开▼
